125 results on '"Hinrichsen H."'
Search Results
2. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients
3. 53/m mit Konzentrationsstörungen und diffusen Arthralgien: Vorbereitung auf die Facharztprüfung: Fall 35
4. Renormalized equations of motion for scalars and fermions in the 2PI formalism.
5. Spatio-temporal dynamics of cod nursery areas in the Baltic Sea
6. Spawning areas of eastern Baltic cod revisited: Using hydrodynamic modelling to reveal spawning habitat suitability, egg survival probability, and connectivity patterns
7. Can sporadic records of ocean sunfish (Mola mola) in the western Baltic Sea be linked to saline inflow events?
8. Reproduction of Baltic cod, Gadus morhua (Actinopterygii: Gadiformes: Gadidae), in the Gotland Basin: Causes of annual variability
9. Real‐world experience with the all‐oral, interferon‐free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry
10. Regressgefahr in der Hepatitis-C-Therapie
11. P052 Comparing T cell responses to food antigens in Inflammatory Bowel Disease patients and healthy donors
12. Spatio-temporal trends in stock mixing of eastern and western Baltic cod in the Arkona Basin and the implications for recruitment
13. Der Wechsel in die Varianttonart als Merkmal des französischen Stils um 1700 : Lully, Couperin, Bach, Händel
14. Response to discontinuation of nucleos(t)ide analogue treatment in HBeAg-negative chronic hepatitis B: results from the Stop-NUC trial
15. Management des Pruritus als extrahepatische Manifestation der PBC - ein Leitfaden für den Praxisalltag
16. Barrieren der Hepatitis-C-Virus (HCV) Elimination in Deutschland: warum erhalten diagnostizierte Patienten keine Therapie?
17. Real-world efficacy of EBR/GZR in HCV GT1 patients with multiple comorbidities and medications: results from the DHC-R
18. High effectiveness of elbasvir/grazoprevir (EBR/GZR) treatment in patients with HCV genotype 1a (GT1a) infection in German real-world: results from the German Hepatitis C Registry (DHC-R)
19. Real World Experience of Prescribing Tenofovir Alafenamide for Chronic Hepatitis B Patients in Germany
20. Real-Life Experiences with Telaprevir in the Treatment of Chronic Genotype 1 Hepatitis C — The TEPS Study
21. High real-world efficacy of elbasvir/grazoprevir (EBR/GZR) in genotype 1 (GT1) infected patients with and without liver cirrhosis: results from the German Hepatitis C Registry (DHC-R)
22. Whole metabolome profiling identifies the combination of an eicosanoid, a bile acid and an androgen as a highly accurate marker of liver fibrosis in patients with non-alcoholic fatty liver disease
23. Biophysical modeling of survival and dispersal of Central and Eastern Baltic Sea flounder (Platichthys flesus) larvae
24. Biophysical modeling of survival and dispersal of Central and Eastern Baltic Sea flounder (Platichthys flesus) larvae
25. Ocean current connectivity propelling the secondary spread of a marine invasive comb jelly across western Eurasia
26. Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion: AWMF-Register-Nr.: 021/012.
27. Utilization of elbasvir/grazoprevir (EBR/GZR) and adoption of resistance associated substitutions (RAS) testing in real-world treatment of HCV genotype 1 (GT1) infection: results from the German Hepatitis C Registry (DHC-R)
28. Prävalenz von HCV NS5A Resistenzen und Therapieansprechen bei DAA-naiven Patienten mit einer chronischen Genotyp (GT) 1a Hepatitis C Virusinfektion
29. Diagnostik der Leberfibrose bei nicht-alkoholischer Fettlebererkrankung mittels Composite Score aus einem Eicosanoid, einer Gallensäure und einem Androgen
30. Utilization of elbasvir/grazoprevir (EBR/GZR) and adoption of resistance associated substitutions (RAS) testing in real-world treatment of HCV genotype 1 (GT1) infection: results from the German Hepatitis C Registry (DHC-R)
31. Therapy with DAAs in patients with chronic hepatitis C and advanced chronic kidney disease: Real-world experience from the German Hepatitis C-Registry (DHC-R)
32. NS5A resistance patterns and treatment outcomes in DAA-naive genotype 1a chronic hepatitis C patients with and without baseline resistance-associated substitutions
33. Therapy with DAAs in patients with chronic hepatitis C and advanced chronic kidney disease: Real-world experience of the German Hepatitis C Registry
34. Evaluierung von Phosphatidylethanol als sensitiver und spezifischer Biomarker zur Abstinenzkontrolle von Patienten mit Indikation zur Lebertransplantation
35. EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis
36. Impact of weight reduction on serum markers and liver histology including progression to cirrhosis in patients with nonalcoholic steatohepatitis (NASH) and bridging fibrosis
37. Real-world evidence on all-oral, interferon-free regimens with Ombitasvir/Paritaprevir/r and Dasabuvir for treatment of chronic HCV patients with renal insufficiency in the German Hepatitis C-Registry
38. Safety and efficacy of daclatasvir plus sofosbuvir with or without ribarivin for hepatitis C post-transplant : interim results from the compassionate use program
39. Spawning areas of eastern Baltic cod revisited : Using hydrodynamic modelling to reveal spawning habitat suitability, egg survival probability, and connectivity patterns
40. Connectivity of larval cod in the transition area between North Sea and Baltic Sea and potential implications for fisheries management
41. Slave to the rhythm: seasonal signals in otolith microchemistry reveal age of eastern Baltic cod (Gadus morhua)
42. Spatio-temporal trends in stock mixing of eastern and western Baltic cod in the Arkona Basin and the implications for recruitment
43. Prävalenz und klinische Bedeutung von Hepatitis C Virus (HCV) Genotyp 2k/1b Chimären
44. Re-Therapie nach Versagen einer ersten Interferon-freien direkt antiviralen HCV-Therapie: „Real World“-Daten aus einer großen HCV-Resistenzdatenbank
45. Beständigkeit des virologischen Ansprechens zu Nachbehandlungswoche 12 (SVR12) bei HCV-Patienten nach Behandlung mit Ombitasvir/Paritaprevir/r und Dasabuvir mit Ribavirin in deutschen Studienzentren
46. Sicherheit und Wirksamkeit direkt antiviraler Substanzkombinationen zur Behandlung der chronischen Hepatitis- C -Virusinfektion bei älteren Patienten (> 70 Jahre): Ergebnisse aus dem Deutschen Hepatitis C-Register (DHC-R)
47. RAVs Datenbank: Untersuchung der Häufigkeit und Charakteristika von RAVs bei therapienaiven und DAA-erfahrenen Patienten
48. Connectivity of larval cod in the transition area between North Sea and Baltic Sea and potential implications for fisheries management
49. European Ravs Database: Frequency and Characteristics of Ravs in Treatment-Naïve and DAA-Experienced Patients
50. Retreatment of Patients who Failed Daa-Combination Therapies: Real-World Experience from a Large Hepatitis C Resistance Database
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.